| 000 | 01716 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513105039.0 | ||
| 264 | 0 | _c19970123 | |
| 008 | 199701s 0 0 eng d | ||
| 022 | _a0013-7227 | ||
| 024 | 7 |
_a10.1210/endo.137.12.8940412 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWebster, E L | |
| 245 | 0 | 0 |
_aIn vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. _h[electronic resource] |
| 260 |
_bEndocrinology _cDec 1996 |
||
| 300 |
_a5747-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdrenocorticotropic Hormone _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aCarrageenan _xadministration & dosage |
| 650 | 0 | 4 |
_aCerebellum _xmetabolism |
| 650 | 0 | 4 |
_aCorticotropin-Releasing Hormone _xmetabolism |
| 650 | 0 | 4 |
_aFrontal Lobe _xmetabolism |
| 650 | 0 | 4 |
_aInflammation _xchemically induced |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 |
_aPituitary Gland _xmetabolism |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 |
_aPyrroles _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Corticotropin-Releasing Hormone _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSheep |
| 700 | 1 | _aLewis, D B | |
| 700 | 1 | _aTorpy, D J | |
| 700 | 1 | _aZachman, E K | |
| 700 | 1 | _aRice, K C | |
| 700 | 1 | _aChrousos, G P | |
| 773 | 0 |
_tEndocrinology _gvol. 137 _gno. 12 _gp. 5747-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/endo.137.12.8940412 _zAvailable from publisher's website |
| 999 |
_c8932742 _d8932742 |
||